HUGE NEWS THIS MORNING FEBRUARY 21, 2017 BY PRESS RELEASE Umbral Initiates Falkland, BC Property Purchase and Prepares for ACMPR Facility Retrofit Submit the press release Vancouver, B.C. / TheNewswire / February 21, 2017 – UMBRAL ENERGY CORP. (CSE: UMB) (the “Company” or “Umbral”) is pleased to announce that it has initiated the purchase of the property located in Falkland, BC. to be used to grow medical cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR) and its 50% interest in an application submitted by PhyeinMed Inc. (“PhyeinMed”).PhyeinMed is a Stage 5 Review applicant owned 50 % by Umbral. The property is a combination of 13 acres of useable development, a 10,000 sq. ft. commercial steel framed building and a residence to be used for executive offices, call centre, accounting and security screening. The medical cannabis grow facility is a short commute from several city centres in the region, allowing for ease of accessibility to labour and shipping requirements. The purchase of the property and the completion of final renovation design and engineering has been initiated and expected to be completed within 90 days. Due to the existence of the current buildings, new structures are not required for the initial phase but a small expansion of one building will be required to accommodate the security measures required for the shipping vestibule. Notifications were sent to the local official departments which included the RCMP, fire department and Columbia Shuswap Regional District as required under the ACMPR. Upon notification to prepare for a pre-license inspection has been received by PhyeinMed from Health Canada, the facility will be well positioned with most if not all of the renovation and security requirements completed. PhyeinMed anticipates that Health Canada will request additional information to confirm that the proposed site and storage security measures are in place, functional and comply with the requirements of the ACMPR and the Directive on Physical Security Requirements for Controlled Substances. In anticipation of the security requirements the Company completed and submitted with its original application thorough standard operating procedures, a master security plan, threat assessment report, vault requirements, site survey plan and architectural drawings to complete the necessary overlays for the security equipment to meet the requirements. Upon completion of the necessary requests and confirmation that the measures are in place Phyeinmed expects an affirmation letter from Health Canada. Although PhyeinMed’s property is 13 acres of potential grow area, the company chooses to utilize the original building of 10,000 sq ft. Perfecting the growing process and utilizing the most technologically advanced systems while maintaining the integrity of the plant and adhering to public health safety are of the utmost importance to the management of PhyeinMed. Future plans utilizing 100% of the land use capabilities could allow for several additional expansion opportunities.
Vancouver, B.C. / TheNewswire / April 13, 2017 - UMBRAL ENERGY CORP. (CSE: UMB) (“ Umbral ” or “Company”) and the the management of PhyeinMed Inc. (“PhyeinMed”) a Health Canada Stage 5 applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations) are pleased to introduce Ms. Zena Prokosh as Regulatory Compliance Advisor to PhyeinMed Inc. Zena Prokosh, CEO and founder of Zreyas Consulting Inc, offers regulatory compliance advice, application assistance, liaison to Health Canada and other related consulting services, to businesses and individuals alike within the cannabis industry, including applicants of all stages, under the ACMPR. Zena holds a B.Sc. in Biology from UBC and acquired her knowledge of medicinal plants while employed as the Curator and Germplasm PlantSMART Research Technician / Lab Manager at the UBC Charles Fipke Centre for Innovative Research, in Kelowna. She applied this experience to cannabis during her tenure as an Alternate Responsible Person In Charge (ARPIC), with THC Biomed International Ltd. During her three years as an ARPIC, she developed a fluency in MMP / ACMP Regulations which, allowed her to play an integral role in navigating the company through the MMPR/ACMPR licensing process, resulting in successfully obtaining a Production License. In addition, Zena has further advanced her knowledge of cannabis through being accepted to and attending the 2016 Masterclass Medicinal Cannabis® held in Leiden, Netherlands, hosted by Dr. Arno Hazekamp." As a side note: Dr. Arno Hazekamp, who's 2013 publication; Hazekamp, A., and Heerdink, E.R. (2013). The prevalence and incidence of medicinal cannabis on prescription in The Netherlands . Eur. J. Clin. Pharmacy. Published online April 16, 2013., was included in an addendum (May 2013) to Health Canada's Information for Health Care Professionals - Cannabis (marihuana, marijuana) and the cannabinoids, to suggest the daily dose of dried cannabis for medical purposes, to be used by patients. Zena will assist PhyeinMed as required with regulatory compliance relating to the application and information requests, quality and security controls during construction and her valuable advice and assistance during Health Canada inspections
New ticker $CANN.c doing amazing. Should join the big boys shortly and see its share price in multi dollars !
So this Jag Bal company was trijet resources.... then did a 2 for 1 rollback and became Umbral.... umbral now changed to CANN and now they are chasing the next hot sector marijuana..... not sure investors have done very well with this fellow heading the companies they have been invested in.... Over a hundred million $ market cap for CANN????? And where is the value? All dependent upon getting a license from Health Canada.?.. not sure that is a slam dunk given their history.